partnerStalicla SA and Evgen Pharma plc ink $160....Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia. more ➔
Clinical Microbiomics A/S bags €10m fina...Danish microbiome specialist Clinical Microbiomics A/S has completed a €10m growth financing led by – Seventure Partners. more ➔
EU starts largest study on factors affecti...The EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence. more ➔
Standing Ovation wins Industria Biotecs...French Standing Ovation has won the start-up pitch of Industria Biotec, held for the first time in Berlin. The event presents biotechnological solutions to save the climate. more ➔
financingAraris Biotech closes $24m Series A financ...Swiss ADC maker Araris Biotech AG has added a $24m financing round to its CHF15.2m (S17.8m) seed round in 2020 to expand its portfolio of proprietary antibody drug conjugates. more ➔
FundingNew Protein Fund I supports 17 alternative...With money from its $50m New Protein Fund, Big Idea Ventures funds in 17 pre-seed plant-based, cell-based and microbial food, ingredient and technology companies. more ➔
Sibylla Biotech raises €23m Series AVerona-based Sibylla Biotech has closed a €23m Series A financing round to advance its Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT) platform. more ➔
AI expert XUND GmbH bags €6m seed financ...Austrian XUND GmbH wants to use the assets of a €6m seed financing to grow in Germany, Switzerland and Austria. more ➔
ADC makeer Pheon Therapeutics raises $68mAntibody-Drug Conjugate (ADC) specialist Pheon Therapeutics Ltd. has closed a $68m Series A financing co-led by Brandon Capital, Forbion and Atlas Venture. more ➔
Kupando raises €13m to push TLR4/7 agoni... Kupando has raised €13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101. more ➔
